For Canadian Residents Only



Maximum Strength Continuous Spray


Menthol 16% w/w

Fast, Long Lasting Relief

Works at any angle

No mess

Accesses hard to reach places



Temporarily relieves aches and pains of muscles and joints, associated with one or more of the following:

Simple backache

✓ Lumbago

✓ Strains

✓ Sprains ( involving muscles, tendons and or ligaments)

✓ Arthritis

available sizes
  • 118 mL
active ingredients - purpose

Menthol 16 % w/w - Topical Analgesic

Adults and children over 12 years of age or older: Spray thinly and evenly to the affected area with desired amount of product, but not more than 3 to 4 times daily. Do not use on children under 12 years of age
Caution: For external use only. Use only as directed. Do not apply to wounds or damaged skin. Do not use if skin is irritated or if irritation develops. Rashes and/or burning discomfort and/or hypersensitivity such as allergy have been known to occur; in these cases, discontinue use. Skin burns (swelling, erythema, bullous lesions, pain) including severe skin burns and skin necrosis have sometimes been reported with products containing menthol. Do not cover with additional bandage or use with external heat such as an electric heating pad as this may result in excessive skin irritation or skin burn. Avoid contact with eyes and mucous membranes. If condition worsens or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use and consult a doctor. If you experience pain, swelling or blistering, stop use and get medical help right away. If you are pregnant or nursing a baby, seek the advice of a doctor before using this product. KEEP THIS AND ALL MEDICINE OUT OF REACH OF CHILDREN. In case of accidental ingestion, seek professional assistance or contact a Poison Control Center immediately. Do not use on children under 12 years of age.
Terms of use
Privacy Policy
This website is intended for Canadian residents only. Icy Hot® is a registered trademark of Sanofi Consumer Health Inc., used under license.
*Sanofi’s calculation based in part on sales data reported by Nielsen through its RMS service for the Topical Analgesics – medicated category for the 52-weeks period ending August 20, 2016, for the Canada market and GB+DR+MM+GM+WC channel according Nielsen standard product hierarchy. Copyright © 2016, The Nielsen Company.
Copyright © 2017 Sanofi Consumer Health Inc. All rights reserved.